Diagnostics To Be Treated Same As Devices Under UDI Program, FDA Says
This article was originally published in The Gray Sheet
Executive Summary
Manufacturers of in vitro diagnostics will be required to take part in FDA’s forthcoming Unique Device Identification (UDI) program, an agency official says.